Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia

Haematologica. 2001 Jul;86(7):772-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Angiogenesis Inhibitors / standards
  • Angiogenesis Inhibitors / toxicity
  • Bone Marrow / pathology
  • Drug Evaluation
  • Humans
  • Neovascularization, Pathologic / drug therapy
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / etiology
  • Thalidomide / administration & dosage*
  • Thalidomide / standards
  • Thalidomide / toxicity

Substances

  • Angiogenesis Inhibitors
  • Thalidomide